Biological activities of a recombinant adenovirus p53 (SCH 58500) administered by hepatic arterial infusion in a Phase 1 colorectal cancer trial.
Atencio IA, Grace M, Bordens R, Fritz M, Horowitz JA, Hutchins B, Indelicato S, Jacobs S, Kolz K, Maneval D, Musco ML, Shinoda J, Venook A, Wen S, Warren R.
Atencio IA, et al. Among authors: indelicato s.
Cancer Gene Ther. 2006 Feb;13(2):169-81. doi: 10.1038/sj.cgt.7700870.
Cancer Gene Ther. 2006.
PMID: 16082381
Clinical Trial.